nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—ABCB1—Methylprednisolone—ankylosing spondylitis	0.106	0.131	CbGbCtD
Etravirine—CYP2C19—Prednisone—ankylosing spondylitis	0.0793	0.0987	CbGbCtD
Etravirine—ABCB1—Betamethasone—ankylosing spondylitis	0.0687	0.0855	CbGbCtD
Etravirine—ABCB1—Prednisolone—ankylosing spondylitis	0.0677	0.0843	CbGbCtD
Etravirine—ABCB1—Prednisone—ankylosing spondylitis	0.064	0.0797	CbGbCtD
Etravirine—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0633	0.0788	CbGbCtD
Etravirine—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0495	0.0616	CbGbCtD
Etravirine—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0479	0.0597	CbGbCtD
Etravirine—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0412	0.0512	CbGbCtD
Etravirine—CYP3A4—Betamethasone—ankylosing spondylitis	0.0411	0.0512	CbGbCtD
Etravirine—CYP3A4—Prednisolone—ankylosing spondylitis	0.0406	0.0505	CbGbCtD
Etravirine—ABCB1—Dexamethasone—ankylosing spondylitis	0.0399	0.0497	CbGbCtD
Etravirine—CYP3A4—Prednisone—ankylosing spondylitis	0.0383	0.0477	CbGbCtD
Etravirine—ABCB1—Methotrexate—ankylosing spondylitis	0.0321	0.04	CbGbCtD
Etravirine—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0239	0.0298	CbGbCtD
Etravirine—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.000517	0.00263	CcSEcCtD
Etravirine—Myocardial infarction—Prednisone—ankylosing spondylitis	0.000517	0.00263	CcSEcCtD
Etravirine—Breast disorder—Methotrexate—ankylosing spondylitis	0.000517	0.00263	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.000515	0.00262	CcSEcCtD
Etravirine—Malaise—Prednisolone—ankylosing spondylitis	0.000511	0.0026	CcSEcCtD
Etravirine—Vertigo—Prednisolone—ankylosing spondylitis	0.000509	0.00259	CcSEcCtD
Etravirine—Syncope—Prednisolone—ankylosing spondylitis	0.000508	0.00258	CcSEcCtD
Etravirine—Eye disorder—Dexamethasone—ankylosing spondylitis	0.000508	0.00258	CcSEcCtD
Etravirine—Eye disorder—Betamethasone—ankylosing spondylitis	0.000508	0.00258	CcSEcCtD
Etravirine—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000498	0.00253	CcSEcCtD
Etravirine—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000493	0.00251	CcSEcCtD
Etravirine—Angiopathy—Betamethasone—ankylosing spondylitis	0.000493	0.00251	CcSEcCtD
Etravirine—Convulsion—Prednisolone—ankylosing spondylitis	0.000491	0.0025	CcSEcCtD
Etravirine—Hypertension—Prednisolone—ankylosing spondylitis	0.00049	0.00249	CcSEcCtD
Etravirine—Eosinophilia—Methotrexate—ankylosing spondylitis	0.000489	0.00249	CcSEcCtD
Etravirine—Pancreatitis—Methotrexate—ankylosing spondylitis	0.000485	0.00246	CcSEcCtD
Etravirine—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000484	0.00246	CcSEcCtD
Etravirine—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000483	0.00245	CcSEcCtD
Etravirine—Discomfort—Prednisolone—ankylosing spondylitis	0.000477	0.00242	CcSEcCtD
Etravirine—Angioedema—Triamcinolone—ankylosing spondylitis	0.000476	0.00242	CcSEcCtD
Etravirine—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000475	0.00242	CcSEcCtD
Etravirine—Malaise—Triamcinolone—ankylosing spondylitis	0.00047	0.00239	CcSEcCtD
Etravirine—Malaise—Methylprednisolone—ankylosing spondylitis	0.000469	0.00238	CcSEcCtD
Etravirine—Vertigo—Triamcinolone—ankylosing spondylitis	0.000468	0.00238	CcSEcCtD
Etravirine—Syncope—Triamcinolone—ankylosing spondylitis	0.000468	0.00238	CcSEcCtD
Etravirine—Vertigo—Methylprednisolone—ankylosing spondylitis	0.000467	0.00237	CcSEcCtD
Etravirine—Syncope—Methylprednisolone—ankylosing spondylitis	0.000467	0.00237	CcSEcCtD
Etravirine—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000465	0.00236	CcSEcCtD
Etravirine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000458	0.00233	CcSEcCtD
Etravirine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000457	0.00232	CcSEcCtD
Etravirine—Shock—Prednisolone—ankylosing spondylitis	0.000455	0.00231	CcSEcCtD
Etravirine—Convulsion—Triamcinolone—ankylosing spondylitis	0.000452	0.0023	CcSEcCtD
Etravirine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000451	0.00229	CcSEcCtD
Etravirine—Hypertension—Triamcinolone—ankylosing spondylitis	0.00045	0.00229	CcSEcCtD
Etravirine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000449	0.00228	CcSEcCtD
Etravirine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000447	0.00227	CcSEcCtD
Etravirine—Eye disorder—Prednisone—ankylosing spondylitis	0.000442	0.00225	CcSEcCtD
Etravirine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.000441	0.00224	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00044	0.00223	CcSEcCtD
Etravirine—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000439	0.00223	CcSEcCtD
Etravirine—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000439	0.00223	CcSEcCtD
Etravirine—Discomfort—Triamcinolone—ankylosing spondylitis	0.000439	0.00223	CcSEcCtD
Etravirine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000438	0.00222	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000437	0.00222	CcSEcCtD
Etravirine—Dry mouth—Triamcinolone—ankylosing spondylitis	0.000434	0.00221	CcSEcCtD
Etravirine—Renal failure—Methotrexate—ankylosing spondylitis	0.000433	0.0022	CcSEcCtD
Etravirine—Angioedema—Dexamethasone—ankylosing spondylitis	0.000432	0.0022	CcSEcCtD
Etravirine—Angioedema—Betamethasone—ankylosing spondylitis	0.000432	0.0022	CcSEcCtD
Etravirine—Stomatitis—Methotrexate—ankylosing spondylitis	0.000429	0.00218	CcSEcCtD
Etravirine—Angiopathy—Prednisone—ankylosing spondylitis	0.000429	0.00218	CcSEcCtD
Etravirine—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.000428	0.00218	CcSEcCtD
Etravirine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000428	0.00218	CcSEcCtD
Etravirine—Immune system disorder—Prednisone—ankylosing spondylitis	0.000427	0.00217	CcSEcCtD
Etravirine—Malaise—Betamethasone—ankylosing spondylitis	0.000427	0.00217	CcSEcCtD
Etravirine—Malaise—Dexamethasone—ankylosing spondylitis	0.000427	0.00217	CcSEcCtD
Etravirine—Vertigo—Betamethasone—ankylosing spondylitis	0.000425	0.00216	CcSEcCtD
Etravirine—Vertigo—Dexamethasone—ankylosing spondylitis	0.000425	0.00216	CcSEcCtD
Etravirine—Syncope—Dexamethasone—ankylosing spondylitis	0.000424	0.00216	CcSEcCtD
Etravirine—Syncope—Betamethasone—ankylosing spondylitis	0.000424	0.00216	CcSEcCtD
Etravirine—Infection—Triamcinolone—ankylosing spondylitis	0.000423	0.00215	CcSEcCtD
Etravirine—Infection—Methylprednisolone—ankylosing spondylitis	0.000422	0.00214	CcSEcCtD
Etravirine—Shock—Triamcinolone—ankylosing spondylitis	0.000419	0.00213	CcSEcCtD
Etravirine—Insomnia—Prednisolone—ankylosing spondylitis	0.000419	0.00213	CcSEcCtD
Etravirine—Shock—Methylprednisolone—ankylosing spondylitis	0.000418	0.00212	CcSEcCtD
Etravirine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000417	0.00212	CcSEcCtD
Etravirine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.000416	0.00212	CcSEcCtD
Etravirine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000416	0.00211	CcSEcCtD
Etravirine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000416	0.00211	CcSEcCtD
Etravirine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000416	0.00211	CcSEcCtD
Etravirine—Mental disorder—Prednisone—ankylosing spondylitis	0.000415	0.00211	CcSEcCtD
Etravirine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000412	0.0021	CcSEcCtD
Etravirine—Malnutrition—Prednisone—ankylosing spondylitis	0.000412	0.00209	CcSEcCtD
Etravirine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.000411	0.00209	CcSEcCtD
Etravirine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00041	0.00209	CcSEcCtD
Etravirine—Convulsion—Dexamethasone—ankylosing spondylitis	0.00041	0.00208	CcSEcCtD
Etravirine—Convulsion—Betamethasone—ankylosing spondylitis	0.00041	0.00208	CcSEcCtD
Etravirine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000408	0.00208	CcSEcCtD
Etravirine—Hypertension—Betamethasone—ankylosing spondylitis	0.000408	0.00208	CcSEcCtD
Etravirine—Anxiety—Dexamethasone—ankylosing spondylitis	0.000401	0.00204	CcSEcCtD
Etravirine—Anxiety—Betamethasone—ankylosing spondylitis	0.000401	0.00204	CcSEcCtD
Etravirine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000398	0.00202	CcSEcCtD
Etravirine—Discomfort—Betamethasone—ankylosing spondylitis	0.000398	0.00202	CcSEcCtD
Etravirine—Pain—Prednisolone—ankylosing spondylitis	0.000396	0.00201	CcSEcCtD
Etravirine—Hepatitis—Methotrexate—ankylosing spondylitis	0.000396	0.00201	CcSEcCtD
Etravirine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.000391	0.00198	CcSEcCtD
Etravirine—Vision blurred—Prednisone—ankylosing spondylitis	0.000388	0.00197	CcSEcCtD
Etravirine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.000388	0.00197	CcSEcCtD
Etravirine—Insomnia—Triamcinolone—ankylosing spondylitis	0.000385	0.00196	CcSEcCtD
Etravirine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000384	0.00195	CcSEcCtD
Etravirine—Infection—Dexamethasone—ankylosing spondylitis	0.000384	0.00195	CcSEcCtD
Etravirine—Infection—Betamethasone—ankylosing spondylitis	0.000384	0.00195	CcSEcCtD
Etravirine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000382	0.00194	CcSEcCtD
Etravirine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000382	0.00194	CcSEcCtD
Etravirine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000381	0.00194	CcSEcCtD
Etravirine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000381	0.00194	CcSEcCtD
Etravirine—Anaemia—Prednisone—ankylosing spondylitis	0.000381	0.00193	CcSEcCtD
Etravirine—Shock—Betamethasone—ankylosing spondylitis	0.00038	0.00193	CcSEcCtD
Etravirine—Shock—Dexamethasone—ankylosing spondylitis	0.00038	0.00193	CcSEcCtD
Etravirine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.000379	0.00192	CcSEcCtD
Etravirine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.000379	0.00192	CcSEcCtD
Etravirine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.000378	0.00192	CcSEcCtD
Etravirine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.000378	0.00192	CcSEcCtD
Etravirine—Angioedema—Prednisone—ankylosing spondylitis	0.000376	0.00191	CcSEcCtD
Etravirine—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000374	0.0019	CcSEcCtD
Etravirine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000373	0.0019	CcSEcCtD
Etravirine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000373	0.0019	CcSEcCtD
Etravirine—Malaise—Prednisone—ankylosing spondylitis	0.000372	0.00189	CcSEcCtD
Etravirine—Vertigo—Prednisone—ankylosing spondylitis	0.00037	0.00188	CcSEcCtD
Etravirine—Eye disorder—Methotrexate—ankylosing spondylitis	0.00037	0.00188	CcSEcCtD
Etravirine—Syncope—Prednisone—ankylosing spondylitis	0.000369	0.00188	CcSEcCtD
Etravirine—Anorexia—Betamethasone—ankylosing spondylitis	0.000368	0.00187	CcSEcCtD
Etravirine—Anorexia—Dexamethasone—ankylosing spondylitis	0.000368	0.00187	CcSEcCtD
Etravirine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.000367	0.00187	CcSEcCtD
Etravirine—Fatigue—Triamcinolone—ankylosing spondylitis	0.000367	0.00186	CcSEcCtD
Etravirine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000366	0.00186	CcSEcCtD
Etravirine—Pain—Triamcinolone—ankylosing spondylitis	0.000364	0.00185	CcSEcCtD
Etravirine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000362	0.00184	CcSEcCtD
Etravirine—Angiopathy—Methotrexate—ankylosing spondylitis	0.000359	0.00182	CcSEcCtD
Etravirine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000357	0.00182	CcSEcCtD
Etravirine—Convulsion—Prednisone—ankylosing spondylitis	0.000357	0.00181	CcSEcCtD
Etravirine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000356	0.00181	CcSEcCtD
Etravirine—Hypertension—Prednisone—ankylosing spondylitis	0.000356	0.00181	CcSEcCtD
Etravirine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000351	0.00178	CcSEcCtD
Etravirine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00035	0.00178	CcSEcCtD
Etravirine—Anxiety—Prednisone—ankylosing spondylitis	0.00035	0.00178	CcSEcCtD
Etravirine—Insomnia—Betamethasone—ankylosing spondylitis	0.000349	0.00177	CcSEcCtD
Etravirine—Insomnia—Dexamethasone—ankylosing spondylitis	0.000349	0.00177	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000348	0.00177	CcSEcCtD
Etravirine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000347	0.00176	CcSEcCtD
Etravirine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000347	0.00176	CcSEcCtD
Etravirine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000347	0.00176	CcSEcCtD
Etravirine—Discomfort—Prednisone—ankylosing spondylitis	0.000347	0.00176	CcSEcCtD
Etravirine—Mental disorder—Methotrexate—ankylosing spondylitis	0.000347	0.00176	CcSEcCtD
Etravirine—Malnutrition—Methotrexate—ankylosing spondylitis	0.000344	0.00175	CcSEcCtD
Etravirine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000341	0.00173	CcSEcCtD
Etravirine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000336	0.00171	CcSEcCtD
Etravirine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000336	0.00171	CcSEcCtD
Etravirine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000336	0.00171	CcSEcCtD
Etravirine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000336	0.00171	CcSEcCtD
Etravirine—Infection—Prednisone—ankylosing spondylitis	0.000334	0.0017	CcSEcCtD
Etravirine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000333	0.00169	CcSEcCtD
Etravirine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000333	0.00169	CcSEcCtD
Etravirine—Fatigue—Dexamethasone—ankylosing spondylitis	0.000333	0.00169	CcSEcCtD
Etravirine—Fatigue—Betamethasone—ankylosing spondylitis	0.000333	0.00169	CcSEcCtD
Etravirine—Shock—Prednisone—ankylosing spondylitis	0.000331	0.00168	CcSEcCtD
Etravirine—Pain—Dexamethasone—ankylosing spondylitis	0.00033	0.00168	CcSEcCtD
Etravirine—Pain—Betamethasone—ankylosing spondylitis	0.00033	0.00168	CcSEcCtD
Etravirine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00033	0.00168	CcSEcCtD
Etravirine—Skin disorder—Prednisone—ankylosing spondylitis	0.000327	0.00166	CcSEcCtD
Etravirine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000325	0.00165	CcSEcCtD
Etravirine—Vision blurred—Methotrexate—ankylosing spondylitis	0.000325	0.00165	CcSEcCtD
Etravirine—Anorexia—Prednisone—ankylosing spondylitis	0.000321	0.00163	CcSEcCtD
Etravirine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000319	0.00162	CcSEcCtD
Etravirine—Anaemia—Methotrexate—ankylosing spondylitis	0.000318	0.00162	CcSEcCtD
Etravirine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000318	0.00162	CcSEcCtD
Etravirine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000318	0.00162	CcSEcCtD
Etravirine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000316	0.0016	CcSEcCtD
Etravirine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000316	0.0016	CcSEcCtD
Etravirine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000314	0.00159	CcSEcCtD
Etravirine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000313	0.00159	CcSEcCtD
Etravirine—Malaise—Methotrexate—ankylosing spondylitis	0.000311	0.00158	CcSEcCtD
Etravirine—Vertigo—Methotrexate—ankylosing spondylitis	0.000309	0.00157	CcSEcCtD
Etravirine—Dizziness—Prednisolone—ankylosing spondylitis	0.000306	0.00155	CcSEcCtD
Etravirine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000305	0.00155	CcSEcCtD
Etravirine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000305	0.00155	CcSEcCtD
Etravirine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000305	0.00155	CcSEcCtD
Etravirine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000305	0.00155	CcSEcCtD
Etravirine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000305	0.00155	CcSEcCtD
Etravirine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000305	0.00155	CcSEcCtD
Etravirine—Insomnia—Prednisone—ankylosing spondylitis	0.000304	0.00155	CcSEcCtD
Etravirine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000302	0.00153	CcSEcCtD
Etravirine—Convulsion—Methotrexate—ankylosing spondylitis	0.000298	0.00152	CcSEcCtD
Etravirine—Decreased appetite—Prednisone—ankylosing spondylitis	0.000292	0.00149	CcSEcCtD
Etravirine—Rash—Prednisolone—ankylosing spondylitis	0.000292	0.00148	CcSEcCtD
Etravirine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000291	0.00148	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000291	0.00148	CcSEcCtD
Etravirine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000291	0.00148	CcSEcCtD
Etravirine—Fatigue—Prednisone—ankylosing spondylitis	0.00029	0.00147	CcSEcCtD
Etravirine—Headache—Prednisolone—ankylosing spondylitis	0.00029	0.00147	CcSEcCtD
Etravirine—Discomfort—Methotrexate—ankylosing spondylitis	0.00029	0.00147	CcSEcCtD
Etravirine—Constipation—Prednisone—ankylosing spondylitis	0.000288	0.00146	CcSEcCtD
Etravirine—Confusional state—Methotrexate—ankylosing spondylitis	0.000283	0.00144	CcSEcCtD
Etravirine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000281	0.00143	CcSEcCtD
Etravirine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000281	0.00143	CcSEcCtD
Etravirine—Infection—Methotrexate—ankylosing spondylitis	0.000279	0.00142	CcSEcCtD
Etravirine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000277	0.00141	CcSEcCtD
Etravirine—Asthenia—Betamethasone—ankylosing spondylitis	0.000277	0.00141	CcSEcCtD
Etravirine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000277	0.00141	CcSEcCtD
Etravirine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000276	0.0014	CcSEcCtD
Etravirine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000275	0.0014	CcSEcCtD
Etravirine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000275	0.0014	CcSEcCtD
Etravirine—Nausea—Prednisolone—ankylosing spondylitis	0.000275	0.0014	CcSEcCtD
Etravirine—Skin disorder—Methotrexate—ankylosing spondylitis	0.000273	0.00139	CcSEcCtD
Etravirine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000272	0.00138	CcSEcCtD
Etravirine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000271	0.00137	CcSEcCtD
Etravirine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00027	0.00137	CcSEcCtD
Etravirine—Rash—Triamcinolone—ankylosing spondylitis	0.000268	0.00136	CcSEcCtD
Etravirine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000268	0.00136	CcSEcCtD
Etravirine—Anorexia—Methotrexate—ankylosing spondylitis	0.000268	0.00136	CcSEcCtD
Etravirine—Rash—Methylprednisolone—ankylosing spondylitis	0.000268	0.00136	CcSEcCtD
Etravirine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000267	0.00136	CcSEcCtD
Etravirine—Headache—Triamcinolone—ankylosing spondylitis	0.000267	0.00135	CcSEcCtD
Etravirine—Headache—Methylprednisolone—ankylosing spondylitis	0.000266	0.00135	CcSEcCtD
Etravirine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000266	0.00135	CcSEcCtD
Etravirine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000266	0.00135	CcSEcCtD
Etravirine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000264	0.00134	CcSEcCtD
Etravirine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000264	0.00134	CcSEcCtD
Etravirine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000255	0.0013	CcSEcCtD
Etravirine—Dizziness—Betamethasone—ankylosing spondylitis	0.000255	0.0013	CcSEcCtD
Etravirine—Insomnia—Methotrexate—ankylosing spondylitis	0.000254	0.00129	CcSEcCtD
Etravirine—Nausea—Triamcinolone—ankylosing spondylitis	0.000253	0.00128	CcSEcCtD
Etravirine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000252	0.00128	CcSEcCtD
Etravirine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000252	0.00128	CcSEcCtD
Etravirine—Somnolence—Methotrexate—ankylosing spondylitis	0.00025	0.00127	CcSEcCtD
Etravirine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000248	0.00126	CcSEcCtD
Etravirine—Vomiting—Betamethasone—ankylosing spondylitis	0.000245	0.00125	CcSEcCtD
Etravirine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000245	0.00125	CcSEcCtD
Etravirine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000244	0.00124	CcSEcCtD
Etravirine—Rash—Betamethasone—ankylosing spondylitis	0.000243	0.00124	CcSEcCtD
Etravirine—Rash—Dexamethasone—ankylosing spondylitis	0.000243	0.00124	CcSEcCtD
Etravirine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000243	0.00124	CcSEcCtD
Etravirine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000243	0.00124	CcSEcCtD
Etravirine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000243	0.00123	CcSEcCtD
Etravirine—Fatigue—Methotrexate—ankylosing spondylitis	0.000242	0.00123	CcSEcCtD
Etravirine—Headache—Betamethasone—ankylosing spondylitis	0.000242	0.00123	CcSEcCtD
Etravirine—Headache—Dexamethasone—ankylosing spondylitis	0.000242	0.00123	CcSEcCtD
Etravirine—Asthenia—Prednisone—ankylosing spondylitis	0.000241	0.00123	CcSEcCtD
Etravirine—Pain—Methotrexate—ankylosing spondylitis	0.00024	0.00122	CcSEcCtD
Etravirine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000232	0.00118	CcSEcCtD
Etravirine—Diarrhoea—Prednisone—ankylosing spondylitis	0.00023	0.00117	CcSEcCtD
Etravirine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00023	0.00117	CcSEcCtD
Etravirine—Nausea—Betamethasone—ankylosing spondylitis	0.000229	0.00117	CcSEcCtD
Etravirine—Nausea—Dexamethasone—ankylosing spondylitis	0.000229	0.00117	CcSEcCtD
Etravirine—Dizziness—Prednisone—ankylosing spondylitis	0.000222	0.00113	CcSEcCtD
Etravirine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000222	0.00113	CcSEcCtD
Etravirine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000222	0.00113	CcSEcCtD
Etravirine—Vomiting—Prednisone—ankylosing spondylitis	0.000214	0.00109	CcSEcCtD
Etravirine—Rash—Prednisone—ankylosing spondylitis	0.000212	0.00108	CcSEcCtD
Etravirine—Dermatitis—Prednisone—ankylosing spondylitis	0.000212	0.00108	CcSEcCtD
Etravirine—Headache—Prednisone—ankylosing spondylitis	0.000211	0.00107	CcSEcCtD
Etravirine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000207	0.00105	CcSEcCtD
Etravirine—Asthenia—Methotrexate—ankylosing spondylitis	0.000202	0.00102	CcSEcCtD
Etravirine—Nausea—Prednisone—ankylosing spondylitis	0.0002	0.00101	CcSEcCtD
Etravirine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000192	0.000977	CcSEcCtD
Etravirine—Dizziness—Methotrexate—ankylosing spondylitis	0.000186	0.000944	CcSEcCtD
Etravirine—Vomiting—Methotrexate—ankylosing spondylitis	0.000179	0.000908	CcSEcCtD
Etravirine—Rash—Methotrexate—ankylosing spondylitis	0.000177	0.0009	CcSEcCtD
Etravirine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000177	0.000899	CcSEcCtD
Etravirine—Headache—Methotrexate—ankylosing spondylitis	0.000176	0.000895	CcSEcCtD
Etravirine—Nausea—Methotrexate—ankylosing spondylitis	0.000167	0.000848	CcSEcCtD
